All articles tagged: Unspecified atrial fibrillation (I48.91)

For patients with atrial fibrillation (AF), pulsed field ablation (PFA) demonstrates a favorable safety profile, according to a study published online July 8 in Nature Medicine.Emmanuel Ekanem, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues examined the safety of PFA by studying postapproval us

For patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage, according to a study published online July 9 in the Annals of Internal Medicine.Tracey G. Simon, M.D., M.P.H., from Brigham and Women's Hospital in Boston, and co

Gastroesophageal reflux disease (GERD) is associated with an increased incidence of atrial fibrillation, according to a study published online June 2 in Frontiers in Cardiovascular Medicine.Lei Wang and Yi Wei Lu, from the Aerospace Center Hospital in Beijing, and colleagues assessed GERD’s role as a potential contributing factor i

Rare predicted loss-of-function (pLOF) variants and a polygenic risk score (PRS) are associated with increased atrial fibrillation (AF) risk, according to a study published online June 26 in JAMA Cardiology.Oliver B. Vad, M.D., from Copenhagen University Hospital–Rigshospitalet in Denmark, and colleagues examined rare pLOF variants as

Patients with atrial fibrillation (AF) on low doses of direct oral anticoagulants (DOACs) have more bleeding episodes than those on standard doses, according to a study published online June 6 in Blood Advances.Gualtiero Palareti, M.D., from Fondazione Arianna Anticoagulazione in Bologna, Italy, and colleagues collected venous b

In patients with atrial fibrillation (AF), those undergoing catheter ablation have a lower risk for incident dementia and mortality, according to a study published online Aug. 23 in the Journal of the American Geriatrics Society.Stephanie L. Harrison, Ph.D., from the University of Liverpool in the United Kingdom, and colleagues examined

In a guideline update issued by the Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology and published online Oct. 28 in the Canadian Journal of Cardiology, new recommendations are presented regarding the use of antiplatelet therapy (APT) for the prevention of atherosclerotic cardiovascular disease.Kevin R.

Postoperative atrial fibrillation (POAF) is associated with an increased rate of neurologic events and worse long-term survival, according to a study published online Sept. 11 in the Journal of Thoracic and Cardiovascular Surgery.Whitney Fu, M.D., from the University of Michigan in Ann Arbor, and colleagues examined the rate of POA

The article discusses Pulsed Field Ablation (PFA) as a breakthrough in atrial fibrillation (AF) treatment. PFA uses electrical pulses to safely target and eliminate AF-causing tissue, offering potential improvements in patient outcomes in cardiac care.

Sleep-related hypoxia is associated with incident atrial fibrillation (AF), according to a study published online Nov. 10 in the Journal of the American Heart Association. Catherine M. Heinzinger, D.O., from the Cleveland Clinic, and colleagues examined the association between sleep-disordered breathing, hypoxia, and pulmon

For nursing home residents with nonvalvular atrial fibrillation, the rate of bleeding is higher with standard- versus reduced-dose direct acting oral anticoagulants (DOACs), according to a study published online Nov. 6 in the Journal of the American Heart Association.Kaleen N. Hayes, Pharm.D., Ph.D., from Brown University School of Pu

Incident atrial fibrillation (AF) is associated with increased risk of mild cognitive impairment (MCI), according to a research letter published online Oct. 25 in JACC: Advances.Sheng-Chia Chung, Ph.D., from University College London, and colleagues examined the association of AF with MCI and subsequent dementia using U.K. primary ele

Reduction seen in pain, nausea, stress, and anxiety, as well as incidence of atrial fibrillation